Leveraging Platform Technology for a Differentiated Gene Therapy Approach
4:00 pm - Wednesday 25th March 2026
- Developing a high purity product profile that reduces total viral load while maximizing efficacy with a novel construct
- Pivotal trial designed with external controls to show differentiation
- Implementing a proactive, short-course immune modulation regimen designed to improve safety outcomes
